Beat COVID-19 - Observational Trial (JUPITER)
Clara Health

Beat COVID-19 - Observational Trial (JUPITER)

Sponsored by Beat COVID


JUPITER is an IRB-approved research study that obtains health information from people to try to identify characteristics and trends that can help beat the COVID-19 / coronavirus pandemic.

Your participation will help researchers better understand COVID-19 and help find ways to defeat COVID-19.

About 
COVID-19

Coronavirus disease 2019 (COVID-19) is a respiratory illness that can spread from person to person. The virus that causes COVID-19 is a novel coronavirus that was first identified during an investigation into an outbreak in Wuhan, China.

How is this study designed?

The JUPITER Study will provide clinical researchers and scientists with a large data set to evaluate and identify trends in order to better understand COVID-19 and stop COVID-19 spread.

Study Type: Observational Estimated Enrollment: 100,000 participants Official Title: A Virtual Observational Protocol to Gain Longitudinal Data in Participants to Help Understand COVID-19 Spread and Disease Progression Actual Study Start Date: April 6, 2020 Estimated Study Completion Date: July 2021

Who is this study for?

Study Population English Speaking adults aged 18 years or older with an ability to self-report their medical history and provide regular updates via an electronic data capture web portal that can be accessed through internet connection.

What should I expect?

Participants are asked questions about COVID-19 testing, exposure, what steps you have taken to stay healthy, medical history, medication/vitamins usage.

How long does it take to participate? After participants are enrolled, about 5-10 minutes.

Participate in the JUPITER study

Thank you for your interest in advancing COVID-19 research.

Please fill out this contact form to be connected to a member of the study team. The following information that you enter will only be authorized to be shared with the research team conducting this specific study.

If you have any difficulties or questions, please contact our support specialists at [email protected]

Have a question?

For general questions about COVID-19 clinical trials, please email [email protected] For study specific inquiries, submit the interest form above.